Genaissance Pharmaceuticals has become part of Clinical Data®, Inc. Founded in 1972, Clinical Data is a worldwide leader in providing comprehensive molecular and pharmacogenomics services as well as clinical diagnostics to improve patient care. 

Clinical Data’s genetic test division, PGxHealth™, builds upon existing assets and know-how acquired from Genaissance Pharmaceuticals in the areas of genomics-based tests and therapeutic efficacy and safety biomarker development for drug utilization.

Clinical Data’s Cogenics™ division provides a comprehensive range of molecular and pharmacogenomics services.  Cogenics offers integrated services for DNA and RNA extraction, genotyping, sequencing, and gene expression as well as serving as a Biorepository for both research and regulated environments. We provide the broadest range of flexible, tailored service solutions on multiple platforms capable of handling from one to tens of thousands of samples.

Click here to update your bookmark

www.cogenics.com